PR Newswire Clinical TrialsOriginal article
AnX Robotica Highlights Documented ProScan AI Workflow Performance from Submission to FDA
RegulatoryProScan AIPositive
AI Analysis
Summary
AnX Robotica announced documented performance results from FDA submissions showing ProScan AI achieves 88.6% mean review-time reduction in small-bowel capsule endoscopy compared to 24.7% with a recently cleared comparator AI workflow.
Outcome Details
FDA submission highlights ProScan AI workflow performance with 88.6% mean review-time reduction compared to 24.7% with comparator AI-assisted workflow
Importance:5/10
Sentiment:
0.70
FDA submissionAI workflowmedical devicecapsule endoscopyperformance data
Read the original article
Published by PR Newswire Clinical Trials on October 11, 2026 4:01 AM